Medicare Enrolled
Dr. Harnish Chawla, M.D.
Cardiovascular Disease · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chawla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chawla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chawla
Dr. Harnish Chawla is a cardiovascular disease specialist in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chawla performed 3,617 Medicare services across 2,927 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chawla received a total of $3,796 from 38 pharmaceutical and/or device companies across 200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chawla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in PA
$3,796 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,617
Medicare services
Top 17% in PA for cardiovascular disease
2,927
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~190 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
1,619 | $7 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
715 | $103 | $251 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
276 | $12 | $92 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
136 | $11 | $160 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
129 | $34 | $407 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
113 | $22 | $97 |
| Cardiac catheterization | 90 | $206 | $4,429 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
83 | $154 | $399 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
68 | $19 | $167 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
56 | $22 | $227 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $123 | $419 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
36 | $460 | $2,098 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $64 | $153 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
34 | $72 | $280 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
27 | $20 | $90 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
22 | $10 | $45 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
20 | $62 | $1,070 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
15 | $4 | $31 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
15 | $22 | $130 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
14 | $81 | $742 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
13 | $19 | $71 |
| Radiologist review of abdominal aorta image A radiologist reviews images of the abdominal aorta to evaluate the blood vessel. |
12 | $58 | $246 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
12 | $22 | $115 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
12 | $32 | $259 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $305 | $4,755 |
| Radiologist review of arm or leg artery images A radiologist reviews images of the arteries in one or both arms or legs to assess blood flow and vessel health. |
11 | $79 | $169 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.2% high complexity
0.9% medium
90.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,796
Total received (2018-2024)
Avg $542/year across 7 years
Top 39% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
200
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,761 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$34 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$920
2023
$787
2022
$404
2021
$345
2020
$78
2019
$676
2018
$585
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$224
Novartis Pharmaceuticals Corporation
$185
Medtronic, Inc.
$184
Amgen Inc.
$69
ATRICURE, INC.
$56
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$37
Novo Nordisk Inc
$34
Inspire Medical Systems, Inc.
$32
AngioDynamics, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$17
Daiichi Sankyo Inc.
$17
Azurity Pharmaceuticals, Inc.
$16
MEDICOMP INC
$16
Janssen Pharmaceuticals, Inc
$16
Top 3 companies account for 64.4% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$509
Boston Scientific Corporation
$425
Medtronic, Inc.
$341
Abbott Laboratories
$334
Novartis Pharmaceuticals Corporation
$316
Amgen Inc.
$281
AstraZeneca Pharmaceuticals LP
$226
ATRICURE, INC.
$168
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$157
Medtronic Vascular, Inc.
$139
Daiichi Sankyo Inc.
$126
Merck Sharp & Dohme LLC
$76
E.R. Squibb & Sons, L.L.C.
$58
Inspire Medical Systems, Inc.
$56
BOSTON SCIENTIFIC CORPORATION
$52
Novo Nordisk Inc
$49
Regeneron Healthcare Solutions, Inc.
$37
ShockWave Medical, Inc
$35
Philips Electronics North America Corporation
$34
Cardiovascular Systems Inc.
$30
Alnylam Pharmaceuticals Inc.
$30
SANOFI-AVENTIS U.S. LLC
$26
Amarin Pharma Inc.
$25
PFIZER INC.
$25
iRhythm Technologies, Inc.
$24
Gilead Sciences, Inc.
$23
Penumbra, Inc.
$20
Edwards Lifesciences Corporation
$20
Lexicon Pharmaceuticals, Inc.
$17
AngioDynamics, Inc.
$17
Janssen Biotech, Inc.
$17
Azurity Pharmaceuticals, Inc.
$16
MEDICOMP INC
$16
Shockwave Medical, Inc
$16
Merck Sharp & Dohme Corporation
$14
Kowa Pharmaceuticals America, Inc.
$13
Lundbeck LLC
$13
Relypsa, Inc.
$12
Top 3 companies account for 33.6% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ABSOLUTE PRO · ACCOLADE SR · ANGIOJET · ATRICLIP LAA EXCLUSION SYSTEM · AURYON LASER SYSTEM 100-120 VAC · Abre · BRILINTA · CAMZYOS · CHANTIX · Corlanor · Diamondback Coronary · EDARBI · ELIQUIS · ELUVIA · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EUPHORA · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · HeartMate · INJECTAFER · INSPIRE · Indigo System · Inpefa · LEQVIO · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MITRACLIP · MULTAQ · Mitra Clip system · NORTHERA · ONPATTRO · ONYX FRONTIER · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Ranexa · Repatha · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SUPERA · SelectSecure · TELEPATCH CARDIAC MONITOR · TELESCOPE · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · Vascepa · Vascular Lithotripsy · Veltassa · WATCHMAN · WATCHMAN Access System · XARELTO · Xience Sierra Coronary Stent System · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
744
Per 100K population
47.0
County median income
$60,698
Nearest hospital
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chawla is a clinical cardiology specialist, with above-average Medicare volume (top 17% in PA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chawla experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Chawla performed 1,619 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chawla receive payments from pharmaceutical companies?
Yes. Dr. Chawla received a total of $3,796 from 38 companies across 200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chawla's costs compare to other cardiologists in Philadelphia?
Dr. Chawla's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chawla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Philadelphia
Browse cardiologists in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology